This is the protocol for a review and there is no abstract. The objectives are as follows:Expand abstract
To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions for the prevention of bleeding (prophylactic platelet transfusion) in patients with haematological disorders who are undergoing myelosuppressive chemotherapy or stem cell transplantation. Anti-...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- John Wiley and Sons, Ltd Publisher's website
- Cochrane database of systematic reviews (Online) Journal website
- Chapter number:
- Publication date:
- Source identifiers:
- Local pid:
- Copyright holder:
- The Cochrane Collaboration
- Copyright date:
This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2014, Issue 3. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd. Citation: Estcourt LJ, Gregg R, Stanworth S, Doree C, Trivella M, Murphy MF, Tinmouth A. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010982. DOI: 10.1002/14651858.CD010982.
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record